Page last updated: 2024-09-04

bz-423 and Leukemia, Myeloid, Acute

bz-423 has been researched along with Leukemia, Myeloid, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altucci, L; Balliu, M; Carafa, V; Cellai, C; Guandalini, L; Laurenzana, A; Matucci, R; Miniati, D; Nebbioso, A; Paoletti, F; Romanelli, MN; Torre, E1

Other Studies

1 other study(ies) available for bz-423 and Leukemia, Myeloid, Acute

ArticleYear
The new low-toxic histone deacetylase inhibitor S-(2) induces apoptosis in various acute myeloid leukaemia cells.
    Journal of cellular and molecular medicine, 2012, Volume: 16, Issue:8

    Topics: Acetylation; Animals; Apoptosis; Benzodiazepines; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Fluorometry; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Leukemia, Myeloid, Acute; Mice; Reactive Oxygen Species; Receptors, GABA-A; Toxicity Tests, Acute

2012